New Zealand Formulary
Menu Close Menu

Fewer cancers.
Better survival.
Equity for all.

Systemic Anti-Cancer Therapy Regimen Library

Home > Respiratory

Respiratory Regimens



Mesothelioma Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
LUNG MESO Metastatic - cARBOplatin and pemetrexed
52691000210106
2.0.0
05/07/2022
LUNG MESO Metastatic - cARBOplatin, pemetrexed and beVACizumab
393361000210107
1.0.0
18/08/2024
LUNG MESO Metastatic - cISplatin and pemetrexed
52711000210108
1.0.0
27/07/2021
LUNG MESO Metastatic - cISplatin, pemetrexed and beVACizumab
393351000210109
1.0.0
18/08/2024
LUNG MESO Metastatic - gemcitabine
506691000210103
1.0.0
26/02/2026
LUNG MESO Metastatic - nivolumab [Q2W] and ipilimumab [Q6W]
392941000210102
1.0.0
26/06/2024
LUNG MESO Metastatic - nivolumab Q2W [flat dosing]
506681000210100
1.0.0
26/02/2026
LUNG MESO Metastatic - nivolumab Q4W [flat dosing]
506671000210102
1.0.0
26/02/2026
LUNG MESO Metastatic - pembrolizumab Q3W [flat dosing]
506661000210108
1.0.0
26/02/2026
LUNG MESO Metastatic - pembrolizumab Q6W [flat dosing]
506651000210105
1.0.0
26/02/2026
LUNG MESO Metastatic - vinORELBine
52571000210106
1.0.0
29/06/2021
LUNG MESO Metastatic - vinORELBine [oral]
393691000210107
1.0.0
18/09/2024

NSCLC Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
LUNG NSCLC Adjuvant - aTEZOLIzumab Q3W
497231000210106
1.0.0
20/03/2025
LUNG NSCLC Adjuvant - cISplatin and pemetrexed
506261000210106
1.0.0
09/04/2025
LUNG NSCLC Adjuvant - cISplatin and vinORELBine [oral] Q3W
496701000210107
1.0.0
29/01/2025
LUNG NSCLC Adjuvant - cISplatin and vinORELBine [oral] Q4W
496691000210107
1.0.0
29/01/2025
LUNG NSCLC Adjuvant - cISplatin and vinORELBine Q3W
58921000210103
1.0.0
26/07/2024
LUNG NSCLC Adjuvant - cISplatin and vinORELBine Q4W
58981000210102
1.0.0
26/07/2024
LUNG NSCLC Adjuvant - osimertinib
263821000210103
1.0.0
28/03/2023
LUNG NSCLC Definitive - [Superior sulcus Pancoast] cISplatin and etoposide chemoradiation
52841000210103
3.0.0
26/07/2024
LUNG NSCLC Definitive - cARBOplatin and PACLItaxel chemoradiation
58901000210106
2.0.0
01/08/2024
LUNG NSCLC Definitive - cISplatin and etoposide chemoradiation
52851000210100
3.0.0
26/07/2024
LUNG NSCLC Definitive - cISplatin and gemcitabine chemoradiation
59291000210101
1.0.0
26/07/2024
LUNG NSCLC Definitive - cISplatin and pemetrexed chemoradiation
393681000210105
1.0.0
18/09/2024
LUNG NSCLC Definitive - cISplatin and vinBLASTine chemoradiation
59271000210100
1.0.0
26/07/2024
LUNG NSCLC Locally advanced - durvalumab Q2W [weight based dosing]
59901000210101
2.0.0
29/04/2025
LUNG NSCLC Locally advanced - durvalumab Q4W [flat dosing]
264071000210108
2.0.0
29/04/2025
LUNG NSCLC Locally advanced/Metastatic - aFATinib
497241000210103
1.0.0
20/03/2025
LUNG NSCLC Locally advanced/Metastatic - alectinib
393341000210106
1.0.0
20/08/2025
LUNG NSCLC Locally advanced/Metastatic - amivantamab
496721000210104
2.0.0
26/02/2026
Components ▾
amivantamab 1050 mg
496731000210102
0.0.14
amivantamab 1400mg
496741000210105
0.0.15
LUNG NSCLC Locally advanced/Metastatic - aTEZOLIzumab Q3W
393331000210103
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - brigatinib
393321000210100
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and gemcitabine
264751000210103
1.0.0
05/07/2023
LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and vinORELBine
264741000210101
1.0.0
05/07/2023
LUNG NSCLC Locally advanced/Metastatic - cARBOplatin and vinORELBine [oral]
496751000210108
1.0.0
29/01/2025
LUNG NSCLC Locally advanced/Metastatic - crizotinib
393311000210105
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - Enhertu [trastuzumab deruxtecan]
393621000210109
1.0.0
05/09/2024
LUNG NSCLC Locally advanced/Metastatic - entrectinib
393301000210108
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - erlotinib
497251000210100
1.0.0
20/03/2025
LUNG NSCLC Locally advanced/Metastatic - gefitinib
497261000210102
1.0.0
20/03/2025
LUNG NSCLC Locally advanced/Metastatic - lorlatinib
393291000210109
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - osimertinib
393711000210109
1.0.0
30/09/2024
LUNG NSCLC Locally advanced/Metastatic - pralsetinib
393281000210107
1.0.0
18/08/2024
LUNG NSCLC Locally advanced/Metastatic - sotorasib
506641000210107
1.0.0
26/02/2026
LUNG NSCLC Metastatic - biNIMEtinib and encorafenib
506271000210100
1.0.0
09/04/2025
LUNG NSCLC Metastatic - cARBOplatin and DOCEtaxel
52831000210106
2.0.0
05/07/2022
LUNG NSCLC Metastatic - cARBOplatin and PACLItaxel
58891000210105
3.0.0
28/03/2023
LUNG NSCLC Metastatic - cARBOplatin and pemetrexed
52821000210109
3.0.0
29/10/2023
LUNG NSCLC Metastatic - cARBOplatin and Q1W PACLItaxel
52551000210103
2.0.0
19/09/2023
LUNG NSCLC Metastatic - cARBOplatin, gemcitabine and pembrolizumab
506621000210101
1.0.0
26/02/2026
LUNG NSCLC Metastatic - cARBOplatin, PACLItaxel and pembrolizumab
52651000210104
3.0.0
28/03/2023
LUNG NSCLC Metastatic - cARBOplatin, PACLItaxel, aTEZOLIzumab and beVACizumab
52641000210102
3.0.0
28/03/2023
LUNG NSCLC Metastatic - cARBOplatin, pemetrexed and pembrolizumab
52671000210107
3.0.0
29/10/2023
LUNG NSCLC Metastatic - cISplatin and gemcitabine
59281000210103
1.0.0
12/05/2022
LUNG NSCLC Metastatic - cISplatin and pemetrexed
58941000210109
2.0.0
29/10/2023
LUNG NSCLC Metastatic - cISplatin and vinORELBine
58911000210108
1.0.0
30/11/2021
LUNG NSCLC Metastatic - cISplatin and vinORELBine [oral]
496771000210100
1.0.0
29/01/2025
LUNG NSCLC Metastatic - daBRAFEnib and tRAMEtinib
52741000210109
3.0.0
17/10/2022
LUNG NSCLC Metastatic - DOCEtaxel Q1W
52801000210101
1.0.0
06/08/2021
LUNG NSCLC Metastatic - DOCEtaxel Q3W
52811000210104
1.0.0
06/08/2021
LUNG NSCLC Metastatic - gemcitabine
263831000210101
2.0.0
29/10/2023
LUNG NSCLC Metastatic - nivolumab Q2W [flat dosing]
52701000210106
3.0.0
17/10/2022
LUNG NSCLC Metastatic - nivolumab Q2W [weight based dosing]
52751000210107
1.0.0
27/07/2021
LUNG NSCLC Metastatic - nivolumab Q4W [flat dosing]
52761000210105
3.0.0
17/10/2022
LUNG NSCLC Metastatic - PACLItaxel Q1W
52681000210109
3.0.0
28/03/2023
LUNG NSCLC Metastatic - pembrolizumab Q3W [flat dosing]
263901000210104
1.0.0
28/03/2023
LUNG NSCLC Metastatic - pembrolizumab Q6W [flat dosing]
393261000210104
1.0.0
18/08/2024
LUNG NSCLC Metastatic - vinORELBine [oral] 60 [day 1 and 8] Q3W
393671000210108
1.0.0
18/09/2024
LUNG NSCLC Metastatic - vinORELBine [oral] 60 Q1W
393661000210102
1.0.0
18/09/2024
LUNG NSCLC Metastatic - vinORELBine 25 Q1W
264221000210100
1.0.0
19/04/2023
LUNG NSCLC Metastatic - vinORELBine 30 [day 1 and 8] Q3W
264231000210103
1.0.0
19/04/2023
LUNG NSCLC Neoadjuvant - cARBOplatin, PACLItaxel and nivolumab
506631000210104
1.0.0
26/02/2026
LUNG NSCLC Neoadjuvant - cISplatin, gemcitabine and nivolumab
393251000210102
1.0.0
18/08/2024
LUNG NSCLC Neoadjuvant - cISplatin, pemetrexed and nivolumab
393241000210100
1.0.0
18/08/2024

Superseded Regimens

Name Sort
Id Sort
Version Sort
Date Sort
LUNG NSCLC Advanced/Metastatic - alectinib
52331000210102
3.0.2
20/08/2025
LUNG NSCLC Metastatic - aFATinib
52721000210103
1.0.2
20/08/2025
LUNG NSCLC Metastatic - aTEZOLIzumab
52731000210101
3.0.2
20/08/2025
LUNG NSCLC Metastatic - crizotinib
52661000210101
1.0.2
20/08/2025
LUNG NSCLC Metastatic - erlotinib
58951000210107
1.0.2
20/08/2025
LUNG NSCLC Metastatic - gefitinib
59011000210103
1.0.2
20/08/2025
LUNG NSCLC NON-Metastatic - alectinib
52401000210103
3.0.2
20/08/2025
LUNG NSCLC NON-Metastatic - aTEZOLIzumab
52771000210104
3.0.2
20/08/2025
LUNG NSCLC NON-Metastatic - crizotinib
52861000210102
1.0.2
20/08/2025
LUNG NSCLC NON-Metastatic - durvalumab
52781000210102
2.1.2
20/08/2025

SCLC Regimens


Published

Name Sort
Id Sort
Version Sort
Date Sort
LUNG SCLC Extensive - cARBOplatin and etoposide
58961000210105
3.0.0
25/07/2024
LUNG SCLC Extensive - cARBOplatin and oral etoposide
58991000210100
3.0.0
25/07/2024
LUNG SCLC Extensive - cARBOplatin, etoposide [IV/oral] and aTEZOLIzumab
506281000210103
1.0.0
09/04/2025
LUNG SCLC Extensive - cARBOplatin, etoposide [IV/oral] and durvalumab
506371000210109
1.0.0
01/05/2025
LUNG SCLC Extensive - cARBOplatin, etoposide and aTEZOLIzumab
393231000210108
1.0.0
18/08/2024
LUNG SCLC Extensive - cARBOplatin, etoposide and durvalumab
393221000210106
2.0.0
29/04/2025
LUNG SCLC Extensive - CAV [CYCLOPHOSPHamide 1000, DOXOrubicin and vinCRISTine]
52871000210108
1.0.0
26/07/2024
LUNG SCLC Extensive - CAV [CYCLOPHOSPHamide 750, DOXOrubicin and vinCRISTine]
57371000210102
1.0.0
26/07/2024
LUNG SCLC Extensive - cISplatin and irinotecan
58971000210104
1.0.0
01/08/2024
LUNG SCLC Extensive - PACLItaxel Q1W
263891000210100
1.0.0
25/07/2024
LUNG SCLC Limited - cARBOplatin and etoposide
57381000210100
3.0.0
26/07/2024
LUNG SCLC Limited - cISplatin and etoposide
57391000210103
2.0.0
26/07/2024
LUNG SCLC Limited - cISplatin and etoposide 60/120 chemoradiation
59001000210100
3.0.0
26/07/2024
LUNG SCLC Limited - cISplatin and etoposide 80/100 chemoradiation
59521000210102
1.0.0
26/07/2024
LUNG SCLC Limited - durvalumab Q4W [flat dosing]
506701000210103
1.0.0
26/02/2026